Skip to main content

AN 322 (Niacin Extended-Release 750 mg)

Pill with imprint AN 322 is Orange, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 322

Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322

Niacin Extended-Release

AN 322
750 mg
19.00 mm
Rx and/or OTC
Drug Class
Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
FD&C Yellow No. 6, hydroxyethyl cellulose (4000 mpa.s at 1%), hypromelloses, polyethylene glycol, ferric oxide red, stearic acid, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0322 Amneal Pharmaceuticals LLC
10135-0613 Marlex Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Related images for "AN 322"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.